TBC1D24 GENE PANEL BY NGS, EDTA BLOOD

image not found

NABL Cap Accredited  
The TBC1D24 Gene Panel by NGS analyzes the TBC1D24 gene to detect variants linked to neurological and epilepsy-related disorders. This test helps clinicians identify underlying genetic causes and guide appropriate management. Metropolis Healthcare uses advanced next-generation sequencing technology to ensure accurate and reliable results. It supports early diagnosis and better treatment planning for individuals with suspected genetic epilepsy syndromes.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 21,000.00

Sample Type: EDTA Blood

Fasting Not Required


Notes: T0502

Frequently Asked Questions (FAQ's):

What does the TBC1D24 Gene Panel include at Metropolis Healthcare?
It includes targeted sequencing of the TBC1D24 gene to detect disease-associated genetic variants.

How does Metropolis Healthcare perform this genetic test?
The laboratory uses high-depth next-generation sequencing (NGS) for precise and reliable variant detection.

Who should undergo the TBC1D24 Gene Panel at Metropolis Healthcare?
Individuals with early-onset epilepsy, developmental delays, or suspected hereditary neurological disorders may benefit from this test.

Why is this gene panel important at Metropolis Healthcare?
It helps identify mutations linked to epilepsy syndromes, supporting accurate diagnosis and personalized care.

Is any special preparation required for this EDTA blood test at Metropolis Healthcare?
No special preparation is needed; a routine EDTA blood sample is sufficient.

How long does it take to receive results from Metropolis Healthcare?
Results are generally provided within the standard turnaround time for genetic testing.

What do positive findings mean in a Metropolis Healthcare report?
Detected variants may explain the cause of symptoms and should be discussed with a genetic counselor or clinician.

Can this test be combined with other NGS panels at Metropolis Healthcare?
Yes, it can be included as part of broader neurological or epilepsy gene panels when clinically indicated

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab